Effect of progesterone therapy versus diet modification on constipation during pregnancy

M. Farghali, Ibrahim Anwar Abdelazim, A. Awadalla, Amr Aziz Khalifa, Y. Elshehawy, A. Omu, Assem A. M. Elbiaa
{"title":"Effect of progesterone therapy versus diet modification on constipation during pregnancy","authors":"M. Farghali, Ibrahim Anwar Abdelazim, A. Awadalla, Amr Aziz Khalifa, Y. Elshehawy, A. Omu, Assem A. M. Elbiaa","doi":"10.4103/2278-960X.194477","DOIUrl":null,"url":null,"abstract":"Background: Pregnant women may experience constipation for the first time or their existing constipation symptoms increase in severity during pregnancy. Aim: To compare the effect of progesterone versus diet modification in the treatment of constipation during pregnancy. Subjects and Methods: Women aged ≥18 years with functional constipation according to the Rome III criteria from obstetrics outpatients′ clinic and midwife practices included in this study. Participants divided into two groups; control group managed with diet modifications and study group pregnant women with threatened miscarriage and advised to take vaginal progesterone ≥1 week. Participants completed a nonvalidated questionnaire created by the authors during the whole week before intake of progesterone or diet modifications and after treatment phase. Independent Student′s t-test and Chi-square (χ2 ) test were used for statistical analysis to compare between two studied groups. Primary outcome measures; change in defecation frequency. Results: Sensation of anorectal obstruction and sensation of incomplete evacuation were significantly less in Group B (progesterone therapy) compared to Group A (diet modification) (54% [154/281] and 62.98% [177/281] vs. 89.76% [614/684] and 91.08% [623/684], respectively) (P = 0.04 and 0.03, respectively). Straining during defecation and manual maneuvers to facilitate evacuation were significantly less in Group B compared to Group A (63.7% [179/281] and 19.9% [56/281] vs. 94.59% [647/684] and 86.54% [592/684], respectively) (P < 0.01 and 0.02, respectively). Episodes of abdominal pain and presence of reflux episodes were also significantly less in Group B compared to Group A (18.5% [52/281] and 17.43% [49/281] vs. 84.11% [589/684] and 75% [513/684], respectively) (P = 0.01 and 0.03, respectively). Conclusions: Estrogen, rather than progesterone, may be a detrimental factor of constipation during pregnancy via decreased bowel movement. Progesterone therapy seems to be effective in the treatment of functional constipation during pregnancy. A randomized placebo controlled trial is required to confirm the data of this study.","PeriodicalId":356195,"journal":{"name":"Journal of Basic and Clinical Reproductive Sciences","volume":"2 1","pages":"0"},"PeriodicalIF":0.0000,"publicationDate":"2016-07-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"3","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Journal of Basic and Clinical Reproductive Sciences","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.4103/2278-960X.194477","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 3

Abstract

Background: Pregnant women may experience constipation for the first time or their existing constipation symptoms increase in severity during pregnancy. Aim: To compare the effect of progesterone versus diet modification in the treatment of constipation during pregnancy. Subjects and Methods: Women aged ≥18 years with functional constipation according to the Rome III criteria from obstetrics outpatients′ clinic and midwife practices included in this study. Participants divided into two groups; control group managed with diet modifications and study group pregnant women with threatened miscarriage and advised to take vaginal progesterone ≥1 week. Participants completed a nonvalidated questionnaire created by the authors during the whole week before intake of progesterone or diet modifications and after treatment phase. Independent Student′s t-test and Chi-square (χ2 ) test were used for statistical analysis to compare between two studied groups. Primary outcome measures; change in defecation frequency. Results: Sensation of anorectal obstruction and sensation of incomplete evacuation were significantly less in Group B (progesterone therapy) compared to Group A (diet modification) (54% [154/281] and 62.98% [177/281] vs. 89.76% [614/684] and 91.08% [623/684], respectively) (P = 0.04 and 0.03, respectively). Straining during defecation and manual maneuvers to facilitate evacuation were significantly less in Group B compared to Group A (63.7% [179/281] and 19.9% [56/281] vs. 94.59% [647/684] and 86.54% [592/684], respectively) (P < 0.01 and 0.02, respectively). Episodes of abdominal pain and presence of reflux episodes were also significantly less in Group B compared to Group A (18.5% [52/281] and 17.43% [49/281] vs. 84.11% [589/684] and 75% [513/684], respectively) (P = 0.01 and 0.03, respectively). Conclusions: Estrogen, rather than progesterone, may be a detrimental factor of constipation during pregnancy via decreased bowel movement. Progesterone therapy seems to be effective in the treatment of functional constipation during pregnancy. A randomized placebo controlled trial is required to confirm the data of this study.
孕激素治疗与饮食改变对妊娠期便秘的影响
背景:孕妇在怀孕期间可能第一次出现便秘或便秘症状加重。目的:比较黄体酮与饮食改变治疗妊娠期便秘的疗效。对象和方法:纳入本研究的产科门诊患者和助产士,年龄≥18岁,符合Rome III标准的功能性便秘妇女。参与者被分成两组;对照组采用饮食调整,研究组有先兆流产的孕妇建议服用阴道孕酮≥1周。参与者在服用黄体酮或改变饮食前和治疗后的一整周内完成了一份由作者制作的未经验证的问卷。两组比较采用独立学生t检验和χ2检验进行统计学分析。主要结局指标;排便频率改变。结果:B组(黄体酮治疗)肛肠梗阻感和排便不完全感明显低于A组(饮食改变)(分别为54%[154/281]和62.98%[177/281]比89.76%[614/684]和91.08% [623/684])(P = 0.04和0.03)。B组排便时拉稀和手动方便排便的比例明显低于A组(分别为63.7%[179/281]和19.9%[56/281]比94.59%[647/684]和86.54% [592/684])(P分别< 0.01和0.02)。与A组相比,B组的腹痛发生率和反流发生率也明显降低(分别为18.5%[52/281]和17.43%[49/281]比84.11%[589/684]和75% [513/684])(P分别为0.01和0.03)。结论:雌激素,而不是黄体酮,可能是怀孕期间肠道蠕动减少导致便秘的一个有害因素。黄体酮治疗似乎是有效的治疗功能性便秘在怀孕期间。需要随机安慰剂对照试验来证实本研究的数据。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
自引率
0.00%
发文量
0
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信